ADC Therapeutics SA
ADCT· NYSE
ADC Therapeutics SA
- Last sale
- Oct 2, 2026 · +5.61%
- Market cap
- $144.26M
- 127.67M shares
- Filings
- 434
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $81,357,000 | reported | |
| FY 2024 | 2024-12-31 | $70,837,000 | reported | |
| FY 2023 | 2023-12-31 | $69,060,000 revised | reported | |
| FY 2022 | 2022-12-31 | $74,908,000 revised | reported | |
| FY 2021 | 2021-12-31 | $33,917,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported | |
| FY 2019 | 2019-12-31 | $2,340,000 | reported | |
| FY 2018 | 2018-12-31 | $1,140,000 | reported |
ADC Therapeutics SA · CIK 1771910 · Engraved from SEC EDGAR
